These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22287204)

  • 1. Treatment of septic shock with continuous HDF using 2 PMMA hemofilters for enhanced intensity.
    Matsumura Y; Oda S; Sadahiro T; Nakamura M; Hirayama Y; Watanabe E; Abe R; Nakada TA; Tateishi Y; Oshima T; Shinozaki K; Hirasawa H
    Int J Artif Organs; 2012 Jan; 35(1):3-14. PubMed ID: 22287204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock.
    Nakada TA; Oda S; Matsuda K; Sadahiro T; Nakamura M; Abe R; Hirasawa H
    Mol Med; 2008; 14(5-6):257-63. PubMed ID: 18327291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock.
    Hirasawa H; Oda S; Matsuda K
    Contrib Nephrol; 2007; 156():365-70. PubMed ID: 17464147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator.
    Nakamura M; Oda S; Sadahiro T; Hirayama Y; Watanabe E; Tateishi Y; Nakada TA; Hirasawa H
    Contrib Nephrol; 2010; 166():73-82. PubMed ID: 20472994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy between continuous hemodiafiltration with a PMMA high-performance membrane dialyzer and a PAN membrane hemofilter in the treatment of septic shock patients with acute renal failure.
    Matsuda K; Moriguchi T; Harii N; Yanagisawa M; Harada D; Sugawara H
    Contrib Nephrol; 2011; 173():182-190. PubMed ID: 21865791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter for severe acute pancreatitis.
    Abe R; Oda S; Shinozaki K; Hirasawa H
    Contrib Nephrol; 2010; 166():54-63. PubMed ID: 20472992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter after polymyxin B-immobilized fiber column therapy of septic shock.
    Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2008; 54(1):129-32. PubMed ID: 18204329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF).
    Nakamura M; Oda S; Sadahiro T; Hirayama Y; Tateishi Y; Abe R; Hirasawa H
    Transfus Apher Sci; 2009 Feb; 40(1):41-7. PubMed ID: 19109071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report.
    Shiga H; Hirasawa H; Nishida O; Oda S; Nakamura M; Mashiko K; Matsuda K; Kitamura N; Kikuchi Y; Fuke N
    Blood Purif; 2014; 38(3-4):211-8. PubMed ID: 25531978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy between continuous hemodiafiltration with a PMMA membrane hemofilter and a PAN membrane hemofilter in the treatment of a patient with septic acute renal failure.
    Matsuda K; Moriguchi T; Harii N; Goto J
    Transfus Apher Sci; 2009 Feb; 40(1):49-53. PubMed ID: 19103511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous hemodiafiltration in the treatment of reactive hemophagocytic syndrome refractory to medical therapy.
    Tateishi Y; Oda S; Sadahiro T; Nakamura M; Hirayama Y; Abe R; Hirasawa H
    Transfus Apher Sci; 2009 Feb; 40(1):33-40. PubMed ID: 19097821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter.
    Oda S; Hirasawa H; Shiga H; Matsuda K; Nakamura M; Watanabe E; Moriguchi T
    Ther Apher Dial; 2005 Aug; 9(4):355-61. PubMed ID: 16076382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of continuous hemodiafiltration with a cytokine-adsorbing hemofilter in the treatment of acute respiratory distress syndrome.
    Matsuda K; Moriguchi T; Oda S; Hirasawa H
    Contrib Nephrol; 2010; 166():83-92. PubMed ID: 20472995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Hemodiafiltration with an AN69ST Hemofilter (AN69ST-CHDF) as FGF-23-Lowering Therapy.
    Yamato M; Minematsu Y; Ikemiya Y; Shibata J; Fujii J; Minato T; Miyagawa S; Takaori K; Tomiyama Y; Nagayama I; Wada A; Ito T; Iwatani H
    Clin Lab; 2016 Dec; 62(12):2349-2354. PubMed ID: 28164555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endotoxin removal in septic shock].
    Matsuda K; Hirasawa H; Oda S; Shiga H; Nakanishi K; Nakamura M
    Nihon Geka Gakkai Zasshi; 2002 Dec; 103(12):880-6. PubMed ID: 12599928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications for and clinical efficacy of continuous hemodiafiltration (CHDF) for severe acute pancreatitis].
    Hirasawa H; Oda S; Shiga H; Matsuda K; Abe R
    Nihon Rinsho; 2004 Nov; 62(11):2094-100. PubMed ID: 15552894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of series double continuous hemodiafiltration using two polymethyl methacrylate membrane hemofilters for patients with hypercytokinemia.
    Ooishi Y; Ishii T; Takahata T; Inagaki N; Akizuki N; Isakozawa Y; Takesawa S; Hirasawa H
    Ther Apher Dial; 2014 Apr; 18(2):132-9. PubMed ID: 24720403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis.
    Hirasawa H; Oda S; Nakamura M; Watanabe E; Shiga H; Matsuda K
    Blood Purif; 2012; 34(2):164-70. PubMed ID: 23095416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro analysis of factors affecting the continuous hemodiafiltration clearance of teicoplanin.
    Sawada M; Uchida M; Yamazaki S; Suzuki T; Suzuki T; Ishii I
    Artif Organs; 2023 Apr; 47(4):667-679. PubMed ID: 36310410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics of Vancomycin Under Continuous Renal Replacement Therapy Using a Polymethylmethacrylate Hemofilter.
    Yamazaki S; Tatebe M; Fujiyoshi M; Hattori N; Suzuki T; Takatsuka H; Uchida M; Suzuki T; Ishii I
    Ther Drug Monit; 2020 Jun; 42(3):452-459. PubMed ID: 31913865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.